Locations
Conditions
Treatments
Institutions
Resources
For researchers
About us
Clinical trials
Neoadjuvant Zanzalintinib Plus Nivolumab in Patients With Locally Advanced and/or Inoperable Clear Cell Renal Cell Carcinoma With or Without Non-measurable Metastasis
Apply
Zanzalintinib & Nivolumab
Neoadjuvant Zanzalintinib Plus Nivolumab in Patients With Locally Advanced and/or Inoperable Clear Cell Renal Cell Carcinoma With or Without Non-measurable Metastasis
Basic information
Step 1/5
Provide your basic information
Age
ZIP code
Back
Next step